Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06732219 · ClinicalTrials.gov registry record · NA
A Single-Arm Pilot Trial for Mitigating Relapse of Severe Problem Behavior
A NA study of Challenging Behavior, sponsored by Auburn University.
- Recruiting
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 2
- Study locations
NCT06732219: Recruiting NA study of Challenging Behavior, sponsored by Auburn University.
NCT06732219 is a NA study of Challenging Behavior that is actively recruiting participants, run by Auburn University. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06732219, a NA study of Challenging Behavior, is actively recruiting participants, sponsored by Auburn University.
- RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of this study is to improve how we teach self-control and communication skills to children and adolescents with challenging behaviors. Researchers aim to find ways to make behavior-change treatments more effective and long-lasting, even when the environment or reinforcement schedules change. The main questions this study will answer are: Can innovative techniques help children maintain learned skills, such as asking for attention or waiting for rewards, when faced with new people, places, or situations? How do cognitive and behavioral factors, like memory, timing, and decision-making, affect the success of treatments? Participants in this study will: Complete assessments to identify preferred activities and understand the causes of challenging behaviors. Learn communication skills to replace challenging behaviors, such as tantrums or crying, with more appropriate actions like asking for attention. Participate in activities designed to understand their individual responses to different types of rewards and delays.
Primary Outcome
The prevalence and magnitude of relapse (e.g., renewal or resurgence) in severe problem behavior (SPB). To assess relapse, we will calculate the highest single-session rate of SPB from the five most recent treatment sessions before a context change or reinforcement downshift (prechange period) and up to the first three sessions after the change (postchange period). If fewer sessions are available in either period, all available data will be used. Relapse will be identified if the maximum rate of
Conditions Studied
Interventions
- BEHAVIORAL Functional Communication Training
- BEHAVIORAL Extinction-Correlated Stimuli
- BEHAVIORAL Caregiver Fading
- BEHAVIORAL Structured-Probe Schedule Thinning
- BEHAVIORAL Multiple-Context Generalization Training
Study Locations (2)
Alabama
- Auburn University - Auburn
Maryland
- Kennedy Krieger Institute - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2024-11-14 |
| Est. Completion | 2026-08 |
| Phase | NA |
What NCT06732219 shows while recruiting
NCT06732219 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Challenging Behavior appearing as the primary indexed condition, and to 5 interventions - of which Functional Communication Training is the first listed.
NCT06732219 reports a single indexed study location in Alabama, Maryland.
Frequently Asked Questions
What is clinical trial NCT06732219 about?
NCT06732219 is a clinical study titled "A Single-Arm Pilot Trial for Mitigating Relapse of Severe Problem Behavior". The goal of this study is to improve how we teach self-control and communication skills to children and adolescents with challenging behaviors. Researchers aim to find ways to make behavior-change treatments more effective and long-lasting, even when the environment or reinforcement schedules change...
What is the current status of trial NCT06732219?
This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2024-11-14. Estimated completion is 2026-08.
What conditions does trial NCT06732219 study?
This clinical trial studies the following conditions: Challenging Behavior.
What interventions are being tested in trial NCT06732219?
The interventions under investigation include: Functional Communication Training (BEHAVIORAL), Extinction-Correlated Stimuli (BEHAVIORAL), Caregiver Fading (BEHAVIORAL), Structured-Probe Schedule Thinning (BEHAVIORAL), Multiple-Context Generalization Training (BEHAVIORAL).
Who is sponsoring clinical trial NCT06732219?
This trial is sponsored by Auburn University, which has 54 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06732219 being conducted?
This trial has 2 study locations across Alabama, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Challenging Behavior
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06732219's enrollment target sits among peer trials
10 1927th of 2000 higher than 26 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI